查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1672808

主动式植入式医疗设备市场（按产品、最终用户和地区划分）

Active Implantable Medical Devices Market, By Product, By End Users, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 197 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球主动植入式医疗设备市场规模预估为 274.1 亿美元，预计到 2032 年将达到 452.1 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.4%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 274.1亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025 年至 2032 年复合年增长率 7.40％ 2032 年金额预测 452.1亿美元
数字。 2025 年各地区主动植入式医疗设备市场占有率（%）
主动式植入式医疗设备市场-IMG1

全球主动植入式医疗设备市场的成长受到全球人口老化加剧和慢性病发病率上升的推动。主动式植入式医疗设备是电池供电的医疗设备，植入人体内部以治疗各种医疗状况。主要的主动植入式医疗设备包括植入式心臟整流去颤器（ICD）、神经刺激设备、植入式药物帮浦。 ICD 广泛用于治疗危及生命的心臟疾病，例如心搏过速和心室颤动。神经刺激设备有助于治疗慢性疼痛以及癫痫和帕金森氏症等神经系统疾病。植入式药物帮浦有助于有效局部输送药物，治疗癌症和关节炎等疾病。持续的医学发展和对开发小型化和技术先进的植入式设备的日益关注可能会在预测期内推动主动植入式医疗设备市场的成长。

市场动态

老龄人口日益增多，慢性病频繁，微创手术需求不断增长，心臟疾病和神经系统疾病发病率不断上升，这些都可能推动全球有源植入式医疗设备市场的成长。根据联合国统计，到2050年，全球60岁及以上人口预计将从目前的10亿增加到21亿。与传统药物疗法和医疗设备相比，植入式医疗设备因其长期疗效和易于远端监控等优势，越来越受到人们的偏好，这推动了有源植入式医疗设备的普及。然而，高成本植入式医疗设备的报销范围有限（尤其是在开发中国家） 、由于安全问题而频繁召回产品以及严格的监管核准可能会阻碍预测期内的市场发展。机器人、生物列印和 3D 列印领域的持续技术创新，以及用于长期植入的小型电池供电设备的开发，可以为有源植入式医疗设备市场参与企业提供成长机会。

研究的主要特点

本报告对全球主动植入式医疗设备市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球有源植入式医疗设备市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。

主要企业包括美敦力、科利耳有限公司、雅培、LivaNova PLC、波士顿科学公司和 Myomo, Inc.

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球有源植入式医疗设备市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。

相关人员可以透过全球主动植入式医疗设备市场分析中使用的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管情景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

4. 全球主动式植入式医疗设备市场-冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年全球主动式植入式医疗设备市场（按产品划分）（十亿美元）

  • 介绍
  • 植入式心臟整流去颤器
  • 植入式心臟心律调节器
  • 辅助人工心臟
  • 植入式心臟监测仪/插入式循环记录器
  • 神经刺激设备
  • 植入式助听器
  • 其他（全自动管瓶填充机等）

6. 2020-2032 年全球主动式植入式医疗设备市场（按最终用户划分）（十亿美元）

  • 介绍
  • 医院
  • 门诊手术中心
  • 专科门诊
  • 其他的

7. 2020 年至 2032 年全球主动式植入式医疗设备市场（按地区划分）（十亿美元）

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第八章 竞争格局

  • 公司简介
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • BIoTronik SE &Co. KG
    • Cochlear Ltd.
    • William Demant Holding A/S
    • Sonova Holding AG
    • MED-EL
    • Nurotron BIoTechnology Co. Ltd.
    • Zimmer Biomet Holdings, Inc.
    • Nevro Corp.
    • Second Sight Medical Products, Inc.
    • Nuvectra Corporation
    • Aleva Neurotherapeutics SA
    • Pixium Vision
    • Retina Implant AG
    • Corindus Vascular Robotics, Inc.

第 9 章分析师建议

  • 兴衰
  • 一致的机会地图

第十章调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1126

Global Active Implantable Medical Devices Market is estimated to be valued at USD 27.41 Bn in 2025 and is expected to reach USD 45.21 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 27.41 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.40% 2032 Value Projection: USD 45.21 Bn
Figure. Active Implantable Medical Devices Market Share (%), By Region 2025
Active Implantable Medical Devices Market - IMG1

Global active implantable medical devices market growth is driven by rising aging population and increasing prevalence of chronic diseases worldwide. Active implantable medical devices are battery-powered medical devices that are implanted inside the human body to treat various medical conditions. Some key active implantable medical devices include implantable cardioverter defibrillators (ICDs), neurostimulators, and implantable drug pumps. ICDs are extensively used to treat life-threatening cardiac conditions like tachycardia and ventricular fibrillation. Neurostimulators help in managing chronic pain as well as neurological disorders such as epilepsy and Parkinson's disease. Implantable drug pumps assist in effective localized drug delivery for conditions like cancer and arthritis. Ongoing medical advancement and growing focus on development of miniaturized and technologically advanced implantable devices can drive the active implantable medical devices market growth during the forecast period.

Market Dynamics:

Rising geriatric population base that is highly susceptible to chronic diseases, increasing demand for minimally invasive procedures, growing prevalence of cardiac disorders and neurological conditions can drive the global active implantable medical devices market growth. According to the United Nations, the population aged 60 years and above is projected to reach 2.1 billion globally by 2050 from 1 billion currently. Growing preference for implantable devices over conventional drug therapy and medical devices due to advantages such as long-term effectiveness and easy remote monitoring can boost adoption of active implantable medical devices. However, limited reimbursement coverage for high-cost implantable devices especially in developing nations, frequent product recalls owing to safety issues, and stringent regulatory approvals can hamper the market growth during the forecast period. Ongoing technological innovation in the field of robotics, bioprinting, 3D printing and development of miniature battery powered devices for long term implantation can offer growth opportunities for active implantable medical devices market players.

Key features of the study:

This report provides in-depth analysis of the global active implantable medical devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global active implantable medical devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Cochlear Ltd, Abbott, LivaNova PLC, Boston Scientific Corporation, Myomo, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global active implantable medical devices market

Detailed Segmentation-

  • By Product
    • Implantable Cardioverter Defibrillators
    • Implantable Cardiac Pacemakers
    • Ventricular Assist Devices
    • Implantable Heart Monitors/Insertable Loop Recorders
    • Neurostimulators
    • Implantable Hearing Devices
    • Others
  • By End Users
    • Hospitals
    • Ambulatory Surgery Center
    • Specialty Clinics
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • Biotronik SE & Co. KG
    • Cochlear Ltd.
    • William Demant Holding A/S
    • Sonova Holding AG
    • MED-EL
    • Nurotron Biotechnology Co. Ltd.
    • Zimmer Biomet Holdings, Inc.
    • Nevro Corp.
    • Second Sight Medical Products, Inc.
    • Nuvectra Corporation
    • Aleva Neurotherapeutics SA
    • Pixium Vision
    • Retina Implant AG
    • Corindus Vascular Robotics, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By End User
    • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Active Implantable Medical Devices Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Active Implantable Medical Devices Market, By Product, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Implantable Cardioverter Defibrillators
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Implantable Cardiac Pacemakers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ventricular Assist Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Implantable Heart Monitors/Insertable Loop Recorders
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurostimulators
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Implantable Hearing Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (fully-automatic vial-filling machine, etc.)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Active Implantable Medical Devices Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgery Center
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Active Implantable Medical Devices Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Medtronic plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boston Scientific Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LivaNova PLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biotronik SE & Co. KG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cochlear Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • William Demant Holding A/S
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sonova Holding AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • MED-EL
    • Nurotron Biotechnology Co. Ltd.
    • Zimmer Biomet Holdings, Inc.
    • Nevro Corp.
    • Second Sight Medical Products, Inc.
    • Nuvectra Corporation
    • Aleva Neurotherapeutics SA
    • Pixium Vision
    • Retina Implant AG
    • Corindus Vascular Robotics, Inc.

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact